This report aims to provide a comprehensive presentation of the global market for Medical Cannabis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Cannabis.
The Medical Cannabis market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical Cannabis market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Cannabis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
BOL Pharma
Tilray
Medreleaf Corporation
Aurora Cannabis, Inc
Canopy Growth Corporation
Insys Therapeutics, Inc
Aphria, Inc
MGC Pharmaceuticals Limited
GW Pharmaceuticals, plc
Medical Marijuana Inc
Medipharm Labs
Segment by Type
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
Segment by Application
Pain
Arthritis
Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Cannabis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Cannabis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Medical Cannabis market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical Cannabis market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Cannabis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
BOL Pharma
Tilray
Medreleaf Corporation
Aurora Cannabis, Inc
Canopy Growth Corporation
Insys Therapeutics, Inc
Aphria, Inc
MGC Pharmaceuticals Limited
GW Pharmaceuticals, plc
Medical Marijuana Inc
Medipharm Labs
Segment by Type
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
Segment by Application
Pain
Arthritis
Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Cannabis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Cannabis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Medical Cannabis Market Overview
1.1 Product Overview and Scope of Medical Cannabis
1.2 Medical Cannabis Segment by Type
1.2.1 Global Medical Cannabis Market Value Comparison by Type (2023-2029)
1.2.2 Tetrahydrocannabinol (THC)
1.2.3 Cannabidiol (CBD)
1.3 Medical Cannabis Segment by Application
1.3.1 Global Medical Cannabis Market Value by Application: (2023-2029)
1.3.2 Pain
1.3.3 Arthritis
1.3.4 Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
1.3.5 Others
1.4 Global Medical Cannabis Market Size Estimates and Forecasts
1.4.1 Global Medical Cannabis Revenue 2018-2029
1.4.2 Global Medical Cannabis Sales 2018-2029
1.4.3 Global Medical Cannabis Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Cannabis Market Competition by Manufacturers
2.1 Global Medical Cannabis Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medical Cannabis Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medical Cannabis Average Price by Manufacturers (2018-2023)
2.4 Global Medical Cannabis Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Cannabis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Cannabis, Product Type & Application
2.7 Medical Cannabis Market Competitive Situation and Trends
2.7.1 Medical Cannabis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Cannabis Players Market Share by Revenue
2.7.3 Global Medical Cannabis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Cannabis Retrospective Market Scenario by Region
3.1 Global Medical Cannabis Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Cannabis Global Medical Cannabis Sales by Region: 2018-2029
3.2.1 Global Medical Cannabis Sales by Region: 2018-2023
3.2.2 Global Medical Cannabis Sales by Region: 2024-2029
3.3 Global Medical Cannabis Global Medical Cannabis Revenue by Region: 2018-2029
3.3.1 Global Medical Cannabis Revenue by Region: 2018-2023
3.3.2 Global Medical Cannabis Revenue by Region: 2024-2029
3.4 North America Medical Cannabis Market Facts & Figures by Country
3.4.1 North America Medical Cannabis Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Cannabis Sales by Country (2018-2029)
3.4.3 North America Medical Cannabis Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medical Cannabis Market Facts & Figures by Country
3.5.1 Europe Medical Cannabis Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Cannabis Sales by Country (2018-2029)
3.5.3 Europe Medical Cannabis Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Cannabis Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Cannabis Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Cannabis Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Cannabis Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medical Cannabis Market Facts & Figures by Country
3.7.1 Latin America Medical Cannabis Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Cannabis Sales by Country (2018-2029)
3.7.3 Latin America Medical Cannabis Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Cannabis Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Cannabis Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Cannabis Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Cannabis Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Medical Cannabis Sales by Type (2018-2029)
4.1.1 Global Medical Cannabis Sales by Type (2018-2023)
4.1.2 Global Medical Cannabis Sales by Type (2024-2029)
4.1.3 Global Medical Cannabis Sales Market Share by Type (2018-2029)
4.2 Global Medical Cannabis Revenue by Type (2018-2029)
4.2.1 Global Medical Cannabis Revenue by Type (2018-2023)
4.2.2 Global Medical Cannabis Revenue by Type (2024-2029)
4.2.3 Global Medical Cannabis Revenue Market Share by Type (2018-2029)
4.3 Global Medical Cannabis Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Cannabis Sales by Application (2018-2029)
5.1.1 Global Medical Cannabis Sales by Application (2018-2023)
5.1.2 Global Medical Cannabis Sales by Application (2024-2029)
5.1.3 Global Medical Cannabis Sales Market Share by Application (2018-2029)
5.2 Global Medical Cannabis Revenue by Application (2018-2029)
5.2.1 Global Medical Cannabis Revenue by Application (2018-2023)
5.2.2 Global Medical Cannabis Revenue by Application (2024-2029)
5.2.3 Global Medical Cannabis Revenue Market Share by Application (2018-2029)
5.3 Global Medical Cannabis Price by Application (2018-2029)
6 Key Companies Profiled
6.1 BOL Pharma
6.1.1 BOL Pharma Corporation Information
6.1.2 BOL Pharma Description and Business Overview
6.1.3 BOL Pharma Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.1.4 BOL Pharma Medical Cannabis Product Portfolio
6.1.5 BOL Pharma Recent Developments/Updates
6.2 Tilray
6.2.1 Tilray Corporation Information
6.2.2 Tilray Description and Business Overview
6.2.3 Tilray Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Tilray Medical Cannabis Product Portfolio
6.2.5 Tilray Recent Developments/Updates
6.3 Medreleaf Corporation
6.3.1 Medreleaf Corporation Corporation Information
6.3.2 Medreleaf Corporation Description and Business Overview
6.3.3 Medreleaf Corporation Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medreleaf Corporation Medical Cannabis Product Portfolio
6.3.5 Medreleaf Corporation Recent Developments/Updates
6.4 Aurora Cannabis, Inc
6.4.1 Aurora Cannabis, Inc Corporation Information
6.4.2 Aurora Cannabis, Inc Description and Business Overview
6.4.3 Aurora Cannabis, Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Aurora Cannabis, Inc Medical Cannabis Product Portfolio
6.4.5 Aurora Cannabis, Inc Recent Developments/Updates
6.5 Canopy Growth Corporation
6.5.1 Canopy Growth Corporation Corporation Information
6.5.2 Canopy Growth Corporation Description and Business Overview
6.5.3 Canopy Growth Corporation Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Canopy Growth Corporation Medical Cannabis Product Portfolio
6.5.5 Canopy Growth Corporation Recent Developments/Updates
6.6 Insys Therapeutics, Inc
6.6.1 Insys Therapeutics, Inc Corporation Information
6.6.2 Insys Therapeutics, Inc Description and Business Overview
6.6.3 Insys Therapeutics, Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Insys Therapeutics, Inc Medical Cannabis Product Portfolio
6.6.5 Insys Therapeutics, Inc Recent Developments/Updates
6.7 Aphria, Inc
6.6.1 Aphria, Inc Corporation Information
6.6.2 Aphria, Inc Description and Business Overview
6.6.3 Aphria, Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Aphria, Inc Medical Cannabis Product Portfolio
6.7.5 Aphria, Inc Recent Developments/Updates
6.8 MGC Pharmaceuticals Limited
6.8.1 MGC Pharmaceuticals Limited Corporation Information
6.8.2 MGC Pharmaceuticals Limited Description and Business Overview
6.8.3 MGC Pharmaceuticals Limited Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.8.4 MGC Pharmaceuticals Limited Medical Cannabis Product Portfolio
6.8.5 MGC Pharmaceuticals Limited Recent Developments/Updates
6.9 GW Pharmaceuticals, plc
6.9.1 GW Pharmaceuticals, plc Corporation Information
6.9.2 GW Pharmaceuticals, plc Description and Business Overview
6.9.3 GW Pharmaceuticals, plc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.9.4 GW Pharmaceuticals, plc Medical Cannabis Product Portfolio
6.9.5 GW Pharmaceuticals, plc Recent Developments/Updates
6.10 Medical Marijuana Inc
6.10.1 Medical Marijuana Inc Corporation Information
6.10.2 Medical Marijuana Inc Description and Business Overview
6.10.3 Medical Marijuana Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Medical Marijuana Inc Medical Cannabis Product Portfolio
6.10.5 Medical Marijuana Inc Recent Developments/Updates
6.11 Medipharm Labs
6.11.1 Medipharm Labs Corporation Information
6.11.2 Medipharm Labs Medical Cannabis Description and Business Overview
6.11.3 Medipharm Labs Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Medipharm Labs Medical Cannabis Product Portfolio
6.11.5 Medipharm Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Cannabis Industry Chain Analysis
7.2 Medical Cannabis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Cannabis Production Mode & Process
7.4 Medical Cannabis Sales and Marketing
7.4.1 Medical Cannabis Sales Channels
7.4.2 Medical Cannabis Distributors
7.5 Medical Cannabis Customers
8 Medical Cannabis Market Dynamics
8.1 Medical Cannabis Industry Trends
8.2 Medical Cannabis Market Drivers
8.3 Medical Cannabis Market Challenges
8.4 Medical Cannabis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Medical Cannabis
1.2 Medical Cannabis Segment by Type
1.2.1 Global Medical Cannabis Market Value Comparison by Type (2023-2029)
1.2.2 Tetrahydrocannabinol (THC)
1.2.3 Cannabidiol (CBD)
1.3 Medical Cannabis Segment by Application
1.3.1 Global Medical Cannabis Market Value by Application: (2023-2029)
1.3.2 Pain
1.3.3 Arthritis
1.3.4 Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
1.3.5 Others
1.4 Global Medical Cannabis Market Size Estimates and Forecasts
1.4.1 Global Medical Cannabis Revenue 2018-2029
1.4.2 Global Medical Cannabis Sales 2018-2029
1.4.3 Global Medical Cannabis Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Cannabis Market Competition by Manufacturers
2.1 Global Medical Cannabis Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medical Cannabis Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medical Cannabis Average Price by Manufacturers (2018-2023)
2.4 Global Medical Cannabis Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Cannabis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Cannabis, Product Type & Application
2.7 Medical Cannabis Market Competitive Situation and Trends
2.7.1 Medical Cannabis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Cannabis Players Market Share by Revenue
2.7.3 Global Medical Cannabis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Cannabis Retrospective Market Scenario by Region
3.1 Global Medical Cannabis Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Cannabis Global Medical Cannabis Sales by Region: 2018-2029
3.2.1 Global Medical Cannabis Sales by Region: 2018-2023
3.2.2 Global Medical Cannabis Sales by Region: 2024-2029
3.3 Global Medical Cannabis Global Medical Cannabis Revenue by Region: 2018-2029
3.3.1 Global Medical Cannabis Revenue by Region: 2018-2023
3.3.2 Global Medical Cannabis Revenue by Region: 2024-2029
3.4 North America Medical Cannabis Market Facts & Figures by Country
3.4.1 North America Medical Cannabis Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Cannabis Sales by Country (2018-2029)
3.4.3 North America Medical Cannabis Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medical Cannabis Market Facts & Figures by Country
3.5.1 Europe Medical Cannabis Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Cannabis Sales by Country (2018-2029)
3.5.3 Europe Medical Cannabis Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Cannabis Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Cannabis Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Cannabis Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Cannabis Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medical Cannabis Market Facts & Figures by Country
3.7.1 Latin America Medical Cannabis Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Cannabis Sales by Country (2018-2029)
3.7.3 Latin America Medical Cannabis Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Cannabis Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Cannabis Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Cannabis Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Cannabis Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Medical Cannabis Sales by Type (2018-2029)
4.1.1 Global Medical Cannabis Sales by Type (2018-2023)
4.1.2 Global Medical Cannabis Sales by Type (2024-2029)
4.1.3 Global Medical Cannabis Sales Market Share by Type (2018-2029)
4.2 Global Medical Cannabis Revenue by Type (2018-2029)
4.2.1 Global Medical Cannabis Revenue by Type (2018-2023)
4.2.2 Global Medical Cannabis Revenue by Type (2024-2029)
4.2.3 Global Medical Cannabis Revenue Market Share by Type (2018-2029)
4.3 Global Medical Cannabis Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Cannabis Sales by Application (2018-2029)
5.1.1 Global Medical Cannabis Sales by Application (2018-2023)
5.1.2 Global Medical Cannabis Sales by Application (2024-2029)
5.1.3 Global Medical Cannabis Sales Market Share by Application (2018-2029)
5.2 Global Medical Cannabis Revenue by Application (2018-2029)
5.2.1 Global Medical Cannabis Revenue by Application (2018-2023)
5.2.2 Global Medical Cannabis Revenue by Application (2024-2029)
5.2.3 Global Medical Cannabis Revenue Market Share by Application (2018-2029)
5.3 Global Medical Cannabis Price by Application (2018-2029)
6 Key Companies Profiled
6.1 BOL Pharma
6.1.1 BOL Pharma Corporation Information
6.1.2 BOL Pharma Description and Business Overview
6.1.3 BOL Pharma Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.1.4 BOL Pharma Medical Cannabis Product Portfolio
6.1.5 BOL Pharma Recent Developments/Updates
6.2 Tilray
6.2.1 Tilray Corporation Information
6.2.2 Tilray Description and Business Overview
6.2.3 Tilray Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Tilray Medical Cannabis Product Portfolio
6.2.5 Tilray Recent Developments/Updates
6.3 Medreleaf Corporation
6.3.1 Medreleaf Corporation Corporation Information
6.3.2 Medreleaf Corporation Description and Business Overview
6.3.3 Medreleaf Corporation Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medreleaf Corporation Medical Cannabis Product Portfolio
6.3.5 Medreleaf Corporation Recent Developments/Updates
6.4 Aurora Cannabis, Inc
6.4.1 Aurora Cannabis, Inc Corporation Information
6.4.2 Aurora Cannabis, Inc Description and Business Overview
6.4.3 Aurora Cannabis, Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Aurora Cannabis, Inc Medical Cannabis Product Portfolio
6.4.5 Aurora Cannabis, Inc Recent Developments/Updates
6.5 Canopy Growth Corporation
6.5.1 Canopy Growth Corporation Corporation Information
6.5.2 Canopy Growth Corporation Description and Business Overview
6.5.3 Canopy Growth Corporation Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Canopy Growth Corporation Medical Cannabis Product Portfolio
6.5.5 Canopy Growth Corporation Recent Developments/Updates
6.6 Insys Therapeutics, Inc
6.6.1 Insys Therapeutics, Inc Corporation Information
6.6.2 Insys Therapeutics, Inc Description and Business Overview
6.6.3 Insys Therapeutics, Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Insys Therapeutics, Inc Medical Cannabis Product Portfolio
6.6.5 Insys Therapeutics, Inc Recent Developments/Updates
6.7 Aphria, Inc
6.6.1 Aphria, Inc Corporation Information
6.6.2 Aphria, Inc Description and Business Overview
6.6.3 Aphria, Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Aphria, Inc Medical Cannabis Product Portfolio
6.7.5 Aphria, Inc Recent Developments/Updates
6.8 MGC Pharmaceuticals Limited
6.8.1 MGC Pharmaceuticals Limited Corporation Information
6.8.2 MGC Pharmaceuticals Limited Description and Business Overview
6.8.3 MGC Pharmaceuticals Limited Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.8.4 MGC Pharmaceuticals Limited Medical Cannabis Product Portfolio
6.8.5 MGC Pharmaceuticals Limited Recent Developments/Updates
6.9 GW Pharmaceuticals, plc
6.9.1 GW Pharmaceuticals, plc Corporation Information
6.9.2 GW Pharmaceuticals, plc Description and Business Overview
6.9.3 GW Pharmaceuticals, plc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.9.4 GW Pharmaceuticals, plc Medical Cannabis Product Portfolio
6.9.5 GW Pharmaceuticals, plc Recent Developments/Updates
6.10 Medical Marijuana Inc
6.10.1 Medical Marijuana Inc Corporation Information
6.10.2 Medical Marijuana Inc Description and Business Overview
6.10.3 Medical Marijuana Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Medical Marijuana Inc Medical Cannabis Product Portfolio
6.10.5 Medical Marijuana Inc Recent Developments/Updates
6.11 Medipharm Labs
6.11.1 Medipharm Labs Corporation Information
6.11.2 Medipharm Labs Medical Cannabis Description and Business Overview
6.11.3 Medipharm Labs Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Medipharm Labs Medical Cannabis Product Portfolio
6.11.5 Medipharm Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Cannabis Industry Chain Analysis
7.2 Medical Cannabis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Cannabis Production Mode & Process
7.4 Medical Cannabis Sales and Marketing
7.4.1 Medical Cannabis Sales Channels
7.4.2 Medical Cannabis Distributors
7.5 Medical Cannabis Customers
8 Medical Cannabis Market Dynamics
8.1 Medical Cannabis Industry Trends
8.2 Medical Cannabis Market Drivers
8.3 Medical Cannabis Market Challenges
8.4 Medical Cannabis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.